A NEW PROCEDURE FOR GROUP SEQUENTIAL-ANALYSIS IN CLINICAL-TRIALS

被引:9
作者
FALISSARD, B
LELLOUCH, J
机构
[1] INSERM U 169, 94807 Villejuif
关键词
CLINICAL TRIALS; GROUP SEQUENTIAL ANALYSIS; INTERIM ANALYSES; LOG-RANK TEST; NOMINAL SIGNIFICANCE LEVEL; NORMAL RESPONSE; REPEATED SIGNIFICANCE TESTS; ROBUSTNESS; SUCCESSION PROCEDURE; SUCCESSION OF SIGNIFICANT TESTS; USER-FRIENDLINESS;
D O I
10.2307/2532297
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since Pocock (1977, Biometrika 64, 191-199), many methods have been developed for group sequential analysis of clinical trials. However, these methods remain underemployed, partly because of inconsistencies of sequential testing [Berry (1987, The Statistician 36, 181-189)]. This paper considers a new approach, which, by requiring that a succession of interim analyses be significant at the alpha-level, both preserves the overall significance level a and does not present some of the inconsistencies of the previous methods. Results are obtained for a normal or binary response and for survival data. A comparison with the usual group sequential testing is also presented.
引用
收藏
页码:373 / 388
页数:16
相关论文
共 11 条
[1]   REPEATED SIGNIFICANCE TESTS ON ACCUMULATING DATA [J].
ARMITAGE, P ;
MCPHERSO.CK ;
ROWE, BC .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1969, 132 :235-&
[2]   THE SEARCH FOR OPTIMALITY IN CLINICAL-TRIALS [J].
ARMITAGE, P .
INTERNATIONAL STATISTICAL REVIEW, 1985, 53 (01) :15-24
[3]  
BERRY DA, 1987, STATISTICIAN, V36, P181
[5]   MONITORING TREATMENT DIFFERENCES IN LONG-TERM CLINICAL-TRIALS [J].
CANNER, PL .
BIOMETRICS, 1977, 33 (04) :603-615
[6]  
Cox D R, 1984, ANAL SURVIVAL DATA
[7]  
Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204
[8]  
McPherson K, 1982, Stat Med, V1, P25, DOI 10.1002/sim.4780010105
[9]   MULTIPLE TESTING PROCEDURE FOR CLINICAL-TRIALS [J].
OBRIEN, PC ;
FLEMING, TR .
BIOMETRICS, 1979, 35 (03) :549-556
[10]   INTERIM ANALYSES FOR RANDOMIZED CLINICAL-TRIALS - THE GROUP SEQUENTIAL APPROACH [J].
POCOCK, SJ .
BIOMETRICS, 1982, 38 (01) :153-162